HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Aortic body tumor — Clinical Guidelines

Overview

Primary malignant tumors of the aorta are exceedingly rare, encompassing various histologic entities such as malignant peripheral nerve sheath tumors, angiosarcomas, chondrosarcomas, and malignant fibrous histiocytomas. These tumors can present with symptoms ranging from localized pain and embolization to systemic manifestations like weight loss and fever.

Diagnosis

Clinical Presentation: Symptoms include lumbago, embolization (peripheral, mesenteric, bowel), fatigue, weight loss, and fever 1 2 5.

Imaging: Contrast-enhanced CT scans and MRI are crucial for identifying intraluminal masses and assessing extent 1 2.

Biopsy and Histology: Essential for definitive diagnosis; immunohistochemical markers (S-100, vimentin, CD34, CK AE1/AE3, SMA) help differentiate tumor types 1 4.

Biochemical Markers: Elevated catecholamines (noradrenaline, dopamine, homovanillic acid) may be indicative in some cases 1.

Management

Surgical Excision: Primary treatment for resectable tumors; complete resection when feasible 1 6.

Endovascular Exclusion: Used transiently to prevent recurrent embolization in cases where surgical resection is not immediately possible 2.

Systemic Therapy: Chemotherapy may be indicated for metastatic disease, as seen in angiosarcoma cases 4.

Postoperative Surveillance: Regular imaging to monitor for local recurrence and metastasis 3 4.

Special Populations

Elderly: Surgical risks increase with age; careful risk-benefit assessment required 1.

Comorbidities: Presence of comorbidities like vasculitis can complicate diagnosis and management 3.

Key Recommendations

Surgical resection is the primary treatment modality for localized primary aortic malignant tumors when feasible (Evidence: Strong 1 6).

Endovascular exclusion can be used as a temporizing measure to prevent recurrent embolization (Evidence: Moderate 2).

Systemic therapy, including chemotherapy, should be considered for metastatic disease (Evidence: Weak 4).

Comprehensive imaging (CT, MRI) is essential for accurate diagnosis and staging (Evidence: Moderate 1 2 4).

Close postoperative monitoring is necessary to detect local recurrence and metastasis (Evidence: Expert opinion 3).

References

1 Mori H, Takagi H. Primary Aortic Malignant Peripheral Nerve Sheath Tumor. Vascular and endovascular surgery 2025. link 2 Peinado Cebrian J, Mestres Alomar G, Rodriguez Carvajal R, Uribe Larach JP, Riambau Alonso V. Diagnosis and treatment of a symptomatic primary thoracic aortic tumor: endovascular exclusion to prevent recurrent embolization. Annals of vascular surgery 2014. link 3 Böhner H, Luther B, Braunstein S, Beer S, Sandmann W. Primary malignant tumors of the aorta: clinical presentation, treatment, and course of different entities. Journal of vascular surgery 2003. link00935-2) 4 Ghanem N, Riede U, Uhrmeister P, Weigang E, Altehoefer C. Epithelioid angiosarcoma of the aorta. VASA. Zeitschrift fur Gefasskrankheiten 2002. link 5 Clark N, Goldenkranz RJ, Maeuser H, Brener BJ, Brief DK, Huston J et al.. Chondrosarcoma of the aorta: a rare source of bowel and lower extremity emboli. Journal of vascular surgery 1998. link70072-2) 6 Guvendik L, Ross JK, Marshall RJ. Primary aortic malignant fibrous histiocytoma: a successfully treated case by surgical excision. The Annals of thoracic surgery 1986. link60588-7) 7 Evans MG, Lana DP, McMichael TL. Aortic body tumour with adjacent ectopic thyroid tissue in a dog. Journal of comparative pathology 1986. link90015-0) 8 van Zwieten MJ, Burek JD, Zurcher C, Hollander CF. Aortic body tumours and hyperplasia in the rat. The Journal of pathology 1979. link

Aortic body tumor